Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Case report

Alemtuzumab/antithymocyte-globulin

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 43-year-old man developed hypotension, dyspnoea, chills and palpitation during treatment with antithymocyte-globulin [rabbit antithymocyte globulin; ATGAM] and he also developed similar allergic reaction during treatment with alemtuzumab [not all routes, dosages and duration of treatments to reaction onsets stated]. …
Literatur
Zurück zum Zitat Venkatachalam K, et al. Successful transplantation in a sensitized patient allergic to commercially available antibody induction agents. American Journal of Transplantation 18 (Suppl. 4): 682 abstr. B154, Jun 2018. Available from: URL: http://doi.org/10.1111/ajt.14918 [abstract] - USA Venkatachalam K, et al. Successful transplantation in a sensitized patient allergic to commercially available antibody induction agents. American Journal of Transplantation 18 (Suppl. 4): 682 abstr. B154, Jun 2018. Available from: URL: http://​doi.​org/​10.​1111/​ajt.​14918 [abstract] - USA
Metadaten
Titel
Alemtuzumab/antithymocyte-globulin
Various toxicities: case report
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-47357-x

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Ceftriaxone

Case report

Multiple drugs

Case report

Prednisone

Case report

Cladribine

Case report

Isotretinoin